Hem › Steatotisk leversjukdom › Arizona › Chandler
Kliniska studier för Steatotisk leversjukdom i Chandler, AZ
10 studier för Steatotisk leversjukdom söker deltagare vid platser i och runt Chandler (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekryterarFas 3
- 89bio Clinical Study Site, Chandler
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekryterarFas 3
- 89bio Clinical Study Site, Chandler
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RekryterarFas 2
- Arizona Liver Health, Chandler
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RekryterarFas 3
- The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekryterarFas 3
- Akero Clinical Study Site, Chandler
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekryterarFas 2
- Arizona Liver Health, Chandler
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RekryterarFas 2
- GSK Investigational Site, Chandler
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekryterarFas 3
- GSK Investigational Site, Chandler
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RekryterarFas 2
- GSK Investigational Site, Chandler
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Rekryterar
- Arizona Liver Health, Chandler
Steatotisk leversjukdom-studier i andra städer
- San Antonio, TX17 studier
- Miami, FL16 studier
- New York City, NY16 studier
- San Diego, CA14 studier
- Houston, TX13 studier
- Austin, TX13 studier
- Richmond, VA12 studier
- Tucson, AZ10 studier
- Orlando, FL9 studier
- Hialeah, FL9 studier
- Dallas, TX9 studier
- St. Louis, MO9 studier
Andra studier i Chandler
- Bröstcancer5 studier
- Icke-småcellig lungcancer5 studier
- Kolorektal cancer5 studier
- Övervikt5 studier
- Magsjukdomar5 studier
- Leversjukdomar4 studier
- Övervikt4 studier
- Typ 2-diabetes4 studier
- Metastaserande cancer4 studier
- Alzheimers sjukdom3 studier
- Hjärt-kärlsjukdom3 studier
- Tjocktarmscancer3 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.